Clinical trial
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain…
NCT00126516 · Nara Medical University, Other · Completed
Key facts
| NCT number | NCT00126516 |
|---|---|
| Title | Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline |
| Official title | Effects of Angiotensin II Receptor Blockers (ARB) and Angiotensin Converting Enzyme Inhibitors (ACEI) on Progression of Silent Brain Infarction and Cognitive Decline in Japanese Patients With Essential Hypertension in the Elderly |
| Lead sponsor | Nara Medical University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Infarction, Hypertension |
| Intervention type | Drug |
| Interventions | Angiotensin II Receptor Antagonists, Angiotensin-converting Enzyme Inhibitors |
| Enrollment | 395 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Aug 4, 2005 |
| Last update posted | Oct 30, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: